Discover 3,601 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,601
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer
Location: Fullerton CA, Duarte CA, San Francisco CA, Murray UT,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT04221542
Phase 1, Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: Fullerton CA, Newport Beach CA, Beverly Hills CA,
Sponsor: Synthekine
Sex: All
Age: 18+
Code: NCT05098132
Phase 1, Phase 2, Recruiting
A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
for
Squamous Non-small-cell Lung Cancer,
Location: Fullerton CA, Los Angeles CA, Scottsdale AZ, Chicago IL,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT06747585
Phase 1, Phase 2, Recruiting
A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
for
Thyroid Disease, Kidney Diseases, Chronic
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18 - 70+
Code: NCT03191188
Recruiting
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
for
Immunoglobulin A Nephropathy (IgAN)
Location: Los Angeles CA, San Dimas CA, Oxnard CA,
Sponsor: Biogen
Sex: All
Age: 18+
Code: NCT06935357
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Santa Monica CA, Phoenix AZ, Gilbert AZ, Tucson AZ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase 1, Phase 2, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Los Angeles CA, Duarte CA, San Diego CA, Las Vegas NV,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Santa Monica CA, Los Angeles CA, Bakersfield CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase 3, Recruiting
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
for
Breast Cancer, Breast Tumor, Cancer of Breast,
Location: Santa Monica CA
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06471673
Phase 1, Phase 2, Recruiting
Intraoperative Electrically-evoked ABRs in Patients Undergoing Vestibular Schwannoma Surgery
for
Deafness
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18 - 70+
Code: NCT05248113
Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
for
Advanced Lung Cancer
Location: Beverly Hills CA, Los Angeles CA, Santa Monica CA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06892548
Phase 1, Phase 2, Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
for
Metastatic Colorectal Adenocarcinoma,
Location: Orange CA, Irvine CA, Beverly Hills CA, Los Angeles CA,
Location: Torrance CA, Ventura CA, La Jolla CA, Salinas CA,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations